Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03824483
Title Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University RECRUITING Evanston Illinois 60208 United States Details
Massachusetts General Hospital (Data Collection and Specimen Analysis) RECRUITING Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering at Basking Ridge RECRUITING Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth RECRUITING Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Commack RECRUITING Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester RECRUITING Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Memorial Sloan Kettering Nassau RECRUITING Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field